To identify novel genetic characterizations involved in PD-L1/2, other immune checkpoints and other driver genes in DLBCL patients and to identify patients that would benefit from immunotherapies and
Background: Quantitative (q) polymerase chain reaction (PCR) cycle threshold (Ct) values represent the number of amplification cycles required for a positive PCR result and are a proxy of pathogen qua
